Figure Legends:
Figure 1. Adjusted time to event plots for chronic
complications, device reinterventions, heart failure hospitalizations,
and all-cause mortality out to 3 years of follow-up in patients treated
with leadless VVI versus transvenous VVI pacing. A) Hazard ratio (HR)
and cumulative incidence function for 3-year chronic complications based
on the Fine-Gray competing risk model. B) HR and cumulative incidence
function for 3-year device reinterventions based on the Fine-Gray
competing risk model. B) HR and cumulative incidence function for 3-year
heart failure hospitalizations based on the Fine-Gray competing risk
model. D) HR and patient mortality rates based on the Cox proportional
hazards model. CI = 95% confidence interval.